Skip to main content
Caplight Logo









Umoove

Umoove

Private
JerusalemHealthcare & Life Scienceshttps://umoove.me

Last Round

Angel

Jan 14, 2014

Total Funding Raised

$3M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Umoove operates in Healthcare & Life Sciences and is based in Jerusalem. Its latest recorded funding round was an Angel round in January 2014.

Umoove is a software company that provides face and eye-tracking technology for mobile devices and healthcare applications.

Sector

Healthcare & Life Sciences

Verticals

Computer Vision, Medical AI, AR/VR Experiences, Mental Health

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Infrastructure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Umoove Comparables

Compare Umoove with similar companies based on industry and business-model similarity.

Umoove comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VisualCamp
83%
Eyeware Tech SA
82%
Visage Technologies AB
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Umoove Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelJan 14, 2014
SeedAug 1, 2012
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Yitzi Kempinski

CEO, Founder & CTO

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors grew 43% MoM, from 2.4K to 3.5K.

  • Aug 22, 2026

    Monthly visitors grew 33% MoM, reaching 2.4K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Umoove Filings

Explore SEC and related filing metadata, where available.

Umoove filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Umoove's valuation, stock price, and market status.

Is Umoove a public or private company?

Umoove is a private company.

What is the current stock price of Umoove?

Umoove is a private company, so its shares have no public market price. Caplight tracks Umoove's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Umoove worth (valuation)?

Valuation information for Umoove is not publicly available.

Can I buy Umoove stock?

Umoove shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Umoove's last funding round?

Umoove's most recent funding round was Angel on January 14, 2014.

Who are the main investors in Umoove?

Investor information for Umoove is not publicly disclosed.

Will Umoove IPO soon?

No public IPO plans have been announced for Umoove.

How can I track Umoove secondary market activity?

Caplight tracks bids, offers, and trades in Umoove's shares on secondary markets.

Firmographic Details

HeadquartersJerusalem
Employee Range4
Year Founded2010
Last FundingJan 14, 2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?